The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Women’s Health Therapeutics-Global Market Insights and Sales Trends 2025

Women’s Health Therapeutics-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1828288

No of Pages : 102

Synopsis
Women's health in dermatology covers a vast array of topics that range from issues surrounding management of skin disease during pregnancy and lactation, available hormonal therapies for conditions such as acne and alopecia, hormonally driven conditions that are linked to dermatologic skin diseases such as polycystic, etc.
The global Women’s Health Therapeutics market size is expected to reach US$ 150590 million by 2029, growing at a CAGR of 5.0% from 2023 to 2029. The market is mainly driven by the significant applications of Women’s Health Therapeutics in various end use industries. The expanding demands from the Below 20 Years Old, 20~50 Years Old and Above 50 Years Old,, are propelling Women’s Health Therapeutics market. Infection, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Pregnancy segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Women’s Health Therapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Women’s Health Therapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Women’s Health Therapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Women’s Health Therapeutics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Women’s Health Therapeutics covered in this report include Bayer AG, Pfizer, Inc., Teva Pharmaceutical, F. Hoffmann-La Roche Ltd., Merck and Co., Inc., Bristol-Myers Squibb Company, AstraZeneca, Novartis AG and Eli Lilly and Company, etc.
The global Women’s Health Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bayer AG
Pfizer, Inc.
Teva Pharmaceutical
F. Hoffmann-La Roche Ltd.
Merck and Co., Inc.
Bristol-Myers Squibb Company
AstraZeneca
Novartis AG
Eli Lilly and Company
GlaxoSmithKline plc
Mylan N.V.
Sanofi
Sun Pharmaceutical Industries Ltd.
CooperSurgical, Inc.
Global Women’s Health Therapeutics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Women’s Health Therapeutics market, Segment by Type:
Infection
Pregnancy
Oncology
Global Women’s Health Therapeutics market, by Application
Below 20 Years Old
20~50 Years Old
Above 50 Years Old
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Women’s Health Therapeutics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index
1 Market Overview of Women’s Health Therapeutics
1.1 Women’s Health Therapeutics Market Overview
1.1.1 Women’s Health Therapeutics Product Scope
1.1.2 Women’s Health Therapeutics Market Status and Outlook
1.2 Global Women’s Health Therapeutics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Women’s Health Therapeutics Market Size by Region (2018-2029)
1.4 Global Women’s Health Therapeutics Historic Market Size by Region (2018-2023)
1.5 Global Women’s Health Therapeutics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Women’s Health Therapeutics Market Size (2018-2029)
1.6.1 North America Women’s Health Therapeutics Market Size (2018-2029)
1.6.2 Europe Women’s Health Therapeutics Market Size (2018-2029)
1.6.3 Asia-Pacific Women’s Health Therapeutics Market Size (2018-2029)
1.6.4 Latin America Women’s Health Therapeutics Market Size (2018-2029)
1.6.5 Middle East & Africa Women’s Health Therapeutics Market Size (2018-2029)
2 Women’s Health Therapeutics Market by Type
2.1 Introduction
2.1.1 Infection
2.1.2 Pregnancy
2.1.3 Oncology
2.2 Global Women’s Health Therapeutics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Women’s Health Therapeutics Historic Market Size by Type (2018-2023)
2.2.2 Global Women’s Health Therapeutics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Women’s Health Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Women’s Health Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Women’s Health Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Women’s Health Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Women’s Health Therapeutics Revenue Breakdown by Type (2018-2029)
3 Women’s Health Therapeutics Market Overview by Application
3.1 Introduction
3.1.1 Below 20 Years Old
3.1.2 20~50 Years Old
3.1.3 Above 50 Years Old
3.2 Global Women’s Health Therapeutics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Women’s Health Therapeutics Historic Market Size by Application (2018-2023)
3.2.2 Global Women’s Health Therapeutics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Women’s Health Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Women’s Health Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Women’s Health Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Women’s Health Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Women’s Health Therapeutics Revenue Breakdown by Application (2018-2029)
4 Women’s Health Therapeutics Competition Analysis by Players
4.1 Global Women’s Health Therapeutics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Women’s Health Therapeutics as of 2022)
4.3 Date of Key Players Enter into Women’s Health Therapeutics Market
4.4 Global Top Players Women’s Health Therapeutics Headquarters and Area Served
4.5 Key Players Women’s Health Therapeutics Product Solution and Service
4.6 Competitive Status
4.6.1 Women’s Health Therapeutics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Bayer AG
5.1.1 Bayer AG Profile
5.1.2 Bayer AG Main Business
5.1.3 Bayer AG Women’s Health Therapeutics Products, Services and Solutions
5.1.4 Bayer AG Women’s Health Therapeutics Revenue (US$ Million) & (2018-2023)
5.1.5 Bayer AG Recent Developments
5.2 Pfizer, Inc.
5.2.1 Pfizer, Inc. Profile
5.2.2 Pfizer, Inc. Main Business
5.2.3 Pfizer, Inc. Women’s Health Therapeutics Products, Services and Solutions
5.2.4 Pfizer, Inc. Women’s Health Therapeutics Revenue (US$ Million) & (2018-2023)
5.2.5 Pfizer, Inc. Recent Developments
5.3 Teva Pharmaceutical
5.3.1 Teva Pharmaceutical Profile
5.3.2 Teva Pharmaceutical Main Business
5.3.3 Teva Pharmaceutical Women’s Health Therapeutics Products, Services and Solutions
5.3.4 Teva Pharmaceutical Women’s Health Therapeutics Revenue (US$ Million) & (2018-2023)
5.3.5 F. Hoffmann-La Roche Ltd. Recent Developments
5.4 F. Hoffmann-La Roche Ltd.
5.4.1 F. Hoffmann-La Roche Ltd. Profile
5.4.2 F. Hoffmann-La Roche Ltd. Main Business
5.4.3 F. Hoffmann-La Roche Ltd. Women’s Health Therapeutics Products, Services and Solutions
5.4.4 F. Hoffmann-La Roche Ltd. Women’s Health Therapeutics Revenue (US$ Million) & (2018-2023)
5.4.5 F. Hoffmann-La Roche Ltd. Recent Developments
5.5 Merck and Co., Inc.
5.5.1 Merck and Co., Inc. Profile
5.5.2 Merck and Co., Inc. Main Business
5.5.3 Merck and Co., Inc. Women’s Health Therapeutics Products, Services and Solutions
5.5.4 Merck and Co., Inc. Women’s Health Therapeutics Revenue (US$ Million) & (2018-2023)
5.5.5 Merck and Co., Inc. Recent Developments
5.6 Bristol-Myers Squibb Company
5.6.1 Bristol-Myers Squibb Company Profile
5.6.2 Bristol-Myers Squibb Company Main Business
5.6.3 Bristol-Myers Squibb Company Women’s Health Therapeutics Products, Services and Solutions
5.6.4 Bristol-Myers Squibb Company Women’s Health Therapeutics Revenue (US$ Million) & (2018-2023)
5.6.5 Bristol-Myers Squibb Company Recent Developments
5.7 AstraZeneca
5.7.1 AstraZeneca Profile
5.7.2 AstraZeneca Main Business
5.7.3 AstraZeneca Women’s Health Therapeutics Products, Services and Solutions
5.7.4 AstraZeneca Women’s Health Therapeutics Revenue (US$ Million) & (2018-2023)
5.7.5 AstraZeneca Recent Developments
5.8 Novartis AG
5.8.1 Novartis AG Profile
5.8.2 Novartis AG Main Business
5.8.3 Novartis AG Women’s Health Therapeutics Products, Services and Solutions
5.8.4 Novartis AG Women’s Health Therapeutics Revenue (US$ Million) & (2018-2023)
5.8.5 Novartis AG Recent Developments
5.9 Eli Lilly and Company
5.9.1 Eli Lilly and Company Profile
5.9.2 Eli Lilly and Company Main Business
5.9.3 Eli Lilly and Company Women’s Health Therapeutics Products, Services and Solutions
5.9.4 Eli Lilly and Company Women’s Health Therapeutics Revenue (US$ Million) & (2018-2023)
5.9.5 Eli Lilly and Company Recent Developments
5.10 GlaxoSmithKline plc
5.10.1 GlaxoSmithKline plc Profile
5.10.2 GlaxoSmithKline plc Main Business
5.10.3 GlaxoSmithKline plc Women’s Health Therapeutics Products, Services and Solutions
5.10.4 GlaxoSmithKline plc Women’s Health Therapeutics Revenue (US$ Million) & (2018-2023)
5.10.5 GlaxoSmithKline plc Recent Developments
5.11 Mylan N.V.
5.11.1 Mylan N.V. Profile
5.11.2 Mylan N.V. Main Business
5.11.3 Mylan N.V. Women’s Health Therapeutics Products, Services and Solutions
5.11.4 Mylan N.V. Women’s Health Therapeutics Revenue (US$ Million) & (2018-2023)
5.11.5 Mylan N.V. Recent Developments
5.12 Sanofi
5.12.1 Sanofi Profile
5.12.2 Sanofi Main Business
5.12.3 Sanofi Women’s Health Therapeutics Products, Services and Solutions
5.12.4 Sanofi Women’s Health Therapeutics Revenue (US$ Million) & (2018-2023)
5.12.5 Sanofi Recent Developments
5.13 Sun Pharmaceutical Industries Ltd.
5.13.1 Sun Pharmaceutical Industries Ltd. Profile
5.13.2 Sun Pharmaceutical Industries Ltd. Main Business
5.13.3 Sun Pharmaceutical Industries Ltd. Women’s Health Therapeutics Products, Services and Solutions
5.13.4 Sun Pharmaceutical Industries Ltd. Women’s Health Therapeutics Revenue (US$ Million) & (2018-2023)
5.13.5 Sun Pharmaceutical Industries Ltd. Recent Developments
5.14 CooperSurgical, Inc.
5.14.1 CooperSurgical, Inc. Profile
5.14.2 CooperSurgical, Inc. Main Business
5.14.3 CooperSurgical, Inc. Women’s Health Therapeutics Products, Services and Solutions
5.14.4 CooperSurgical, Inc. Women’s Health Therapeutics Revenue (US$ Million) & (2018-2023)
5.14.5 CooperSurgical, Inc. Recent Developments
6 North America
6.1 North America Women’s Health Therapeutics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Women’s Health Therapeutics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Women’s Health Therapeutics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Women’s Health Therapeutics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Women’s Health Therapeutics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Women’s Health Therapeutics Market Dynamics
11.1 Women’s Health Therapeutics Industry Trends
11.2 Women’s Health Therapeutics Market Drivers
11.3 Women’s Health Therapeutics Market Challenges
11.4 Women’s Health Therapeutics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

Published By : QY Research

Why ‘The Market Reports’